Associated Papers
Discriminating activating, deactivating and resistance variants in protein kinases.
Singh G et al.
Genome Medicine, 2025
ANKK1 Is a Wnt/PCP Scaffold Protein for Neural F-ACTIN Assembly.
Domínguez-Berzosa L et al.
International Journal of Molecular Sciences, 2024
Genomic characteristics and immune landscape of super multiple primary lung cancer.
Yang Z et al.
Ebiomedicine, 2024
Decoding the genetic relationship between Alzheimer's disease and type 2 diabetes: potential risk variants and future direction for North Africa.
Boukhalfa W et al.
Frontiers in Aging Neuroscience, 2023
Genomic, transcriptomic, and metabolomic profiles of hiPSC-derived dopamine neurons from clinically discordant brothers with identical PRKN deletions.
Cukier HN et al.
Npj Parkinson's Disease, 2022
Motivational learning biases are differentially modulated by genetic determinants of striatal and prefrontal dopamine function.
Richter A et al.
Journal of Neural Transmission (vienna, Austria : 1996), 2021
Analysis of genomic pathogenesis according to the revised Bethesda guidelines and additional criteria.
Kim JC et al.
Journal of Cancer Research and Clinical Oncology, 2021
Association of ANKK1 polymorphism with antipsychotic-induced hyperprolactinemia.
Fedorenko OY et al.
Human Psychopharmacology, 2020
Ankyrin Repeat and Kinase Domain Containing 1 Gene, and Addiction Vulnerability.
Koeneke A et al.
International Journal of Molecular Sciences, 2020
A neurobiological pathway to smoking in adolescence: TTC12-ANKK1-DRD2 variants and reward response.
Macare C et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology, 2018
Novel human genome variants associated with alcohol use disorders identified in a Lithuanian cohort.
Baronas K et al.
Acta Medica Lituanic, 2018
Overlapping dopaminergic pathway genetic susceptibility to heroin and cocaine addictions in African Americans.
Levran O et al.
Annals of Human Genetics, 2015
Updated findings of the association and functional studies of DRD2/ANKK1 variants with addictions.
Ma Y et al.
Molecular Neurobiology, 2015
Novel gene identified in an exome-wide association study of tanning dependence.
Cartmel B et al.
Experimental Dermatology, 2014
Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction.
Levran O et al.
Pharmacogenomics, 2013
Motivational salience and genetic variability of dopamine D2 receptor expression interact in the modulation of interference processing.
Richter A et al.
Frontiers in Human Neuroscience, 2013
Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood.
Nemoda Z et al.
Neuroscience and Biobehavioral Reviews, 2011
The ANKK1 protein associated with addictions has nuclear and cytoplasmic localization and shows a differential response of Ala239Thr to apomorphine.
Garrido E et al.
Neurotoxicity Research, 2011
Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations.
Gelernter J et al.
Human Molecular Genetics, 2006